Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents.

Doctors gave adults with intellectual disability different doses of thioridazine. They watched how hyperactivity, self-injury, and stereotypy changed.

The study used a single-case design in a state hospital. Each person got high dose, low dose, and placebo in random order.

Higher dose slightly lowered hyperactivity and self-biting compared with the low dose. The change only showed up in residents who already rocked or waved a lot.

Drug versus placebo made no clear difference overall. The team called the results mixed.

Fyfe et al. (2007) wiped out stereotypy in three adults by adding a punishment cue. Their near-zero rates make the small drug drop look weak.

McGee et al. (1983) saw the same rule in monkeys: d-amphetamine only worsened self-biting in animals that already did it. Both papers say baseline behavior sets the drug effect.

Plant et al. (2007) linked low eye-blink rate to dopamine-driven stereotypy. Thioridazine blocks dopamine, yet the benefit stayed tiny, hinting that chemistry is only part of the story.

You now have two paths for stereotypy: small chemical tweak or strong behavioral cue. Try behavior first—it's faster and bigger. If a doctor raises antipsychotic dose, measure only the top stereotypy cases; others likely waste the med and risk side effects.